Home › Alpha-1 Antitrypsin Deficiency › New York › New York City
Alpha-1 Antitrypsin Deficiency clinical trials in New York City, NY
4 studies for Alpha-1 Antitrypsin Deficiency are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Gene Therapy for Alpha 1- Antitrypsin Deficiency
RecruitingPhase 1
- WCMC Department of Genetic Medicine, New York
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
RecruitingPhase 3
- NYU Langone Health, New York
- Columbia University Irving Medical Center, New York
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
RecruitingPhase 3
- NYU Langone Medical Center, New York
- Columbia University Irving Medical Center, New York
PiMZ Longitudinal Cohort (PiMZ Logic)
RecruitingObservational study
- Columbia University Irving Medical Center, New York
About Alpha-1 Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency is an inherited condition that raises your risk for lung and liver disease. Learn about the symptoms and treatment.
More about Alpha-1 Antitrypsin Deficiency on MedlinePlus
Alpha-1 Antitrypsin Deficiency trials in other cities
- Charleston, SC6 studies
- Gainesville, FL6 studies
- Birmingham, AL5 studies
- Rochester, MN4 studies
- Boston, MA4 studies
- Phoenix, AZ3 studies
- Miami, FL3 studies
- Cleveland, OH3 studies
- Los Angeles, CA3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.